SCHEMBL3145666

SCHEMBL3145666

CCCC(C)(C(=O)OCC)C(=O)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 2/20 0.48
CYP4F2 P78329 3/20 0.47
CYP4A11 Q02928 3/20 0.47
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PKM P14618 3/20 0.42
THRB P10828 1/20 0.42
LMNA P02545 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTT P42858 1/20 0.41
KDM4E B2RXH2 1/20 0.39
ALOX15 P16050 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16976302 0.89 MMP8 (0.44) MMP8CYP4F2CYP4A11MEN1KMT2A
SCHEMBL7508728 0.86 CYP4F2 (0.48) MMP8CYP4F2CYP4A11MEN1KMT2A
SCHEMBL6067652 0.85 MEN1 (0.54) MMP8CYP4F2CYP4A11MEN1KMT2A
SCHEMBL29082645 0.84 LMNA (0.41) MMP8CYP4F2CYP4A11MEN1KMT2A
SCHEMBL13662689 0.84 CYP4F2 (0.55) MMP8CYP4F2CYP4A11MEN1KMT2A
SCHEMBL25189076 0.83 MEN1 (0.57) MMP8CYP4F2CYP4A11MEN1KMT2A
SCHEMBL7510917 0.83 MEN1 (0.57) MMP8CYP4F2CYP4A11MEN1KMT2A
SCHEMBL14502372 0.83 MEN1 (0.57) MMP8CYP4F2CYP4A11MEN1KMT2A
SCHEMBL10631549 0.83 MEN1 (0.57) MMP8CYP4F2CYP4A11MEN1KMT2A
SCHEMBL7508348 0.83 MEN1 (0.57) MMP8CYP4F2CYP4A11MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114805647-A Catalyst composition for olefin polymerization and application thereof 北京肯佰恩科技发展有限公司 2022-07-29 CN claimed
EP-3053935-B1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME CHINA PETROLEUM & CHEM CORP (CN) 2019-05-08 EP claimed
US-9822196-B2 Catalyst composition for olefin polymerization and application of same CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2017-11-21 US claimed
CN-104513330-B A kind of catalyst systems for olefin polymerization and its application 中国石油化工股份有限公司 2017-07-28 CN claimed
CN-104513332-B Catalyst system and its application for olefinic polymerization 中国石油化工股份有限公司 2017-06-06 CN claimed
US-20160244538-A1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2016-08-25 US claimed
EP-3053935-A1 CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION AND APPLICATION OF SAME China Petroleum & Chemical Corporation (CN) 2016-08-10 EP claimed
CN-118909170-A Catalyst system for preparing olefin polymer and application thereof 中国石油化工股份有限公司 2024-11-08 CN disclosed
CN-114805647-B Catalyst composition for olefin polymerization and application thereof 北京肯佰恩科技发展有限公司 2024-03-29 CN disclosed
CN-113912755-B Catalyst composition for olefin polymerization and application thereof 张一锴 2023-06-02 CN disclosed
CN-114805647-A Catalyst composition for olefin polymerization and application thereof 北京肯佰恩科技发展有限公司 2022-07-29 CN disclosed
EP-4015511-A1 OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS CARNEGIE MELLON UNIVERSITY (US) 2022-06-22 EP disclosed
CN-113912755-A Catalyst composition for olefin polymerization and application thereof 张一锴 2022-01-11 CN disclosed
US-8877936-B2 Ruthenium olefin metathesis catalysts bearing N-heterocyclic carbene ligands with substituted backbone CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-11-04 US disclosed
US-20100076074-A1 CARBAMATE REDUCERS OF SKELETAL MUSCLE TENSION AUSPEX PHARMACEUTICALS, INC. (US) 2010-03-25 US disclosed
US-20100076074-A1 CARBAMATE REDUCERS OF SKELETAL MUSCLE TENSION AUSPEX PHARMACEUTICALS, INC. (US) 2010-03-25 US disclosed
US-20100076074-A1 CARBAMATE REDUCERS OF SKELETAL MUSCLE TENSION AUSPEX PHARMACEUTICALS, INC. (US) 2010-03-25 US disclosed
US-7060818-B2 Synthesis of macrocyclic tetraamido compounds and new metal insertion process CARNEGIE MELLON UNIVERSITY (US) 2006-06-13 US disclosed
EP-0914206-B1 LONG-LIVED HOMOGENOUS OXIDATION CATALYSTS UNIV CARNEGIE MELLON (US) 2002-12-11 EP disclosed
EP-0294228-A2 Novel heterocyclic pesticidal compounds THE WELLCOME FOUNDATION LIMITED (GB) 1988-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076074-A1 CARBAMATE REDUCERS OF SKELETAL MUSCLE TENSION TNNC1, MUSK, MYLK2 MMP8 1342/4885CYP4F2 1232/4885CYP4A11 993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.